Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
Sanmai has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Sanmai's investors include Future Ventures, PsyMed Ventures, Reid Hoffman.
Sanmai is headquartered in Los Altos, United States.
Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
Sanmai is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sanmai — Funding & Investors." VCBacked, June 23, 2025, https://www.vcbacked.co/company/sanmai. Accessed August 14, 2026.
VCBacked. (2025). Sanmai — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sanmai
{{cite web |title=Sanmai — Funding & Investors |url=https://www.vcbacked.co/company/sanmai |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated